INS and type 2 diabetes mellitus: As reported, β‐cell specific Gαs deficiency leads to insulin‐deficient diabetes, reduced glucose‐stimulated insulin secretion, and decreased β cell proliferation, which contributes to the progressive decline of β cell mass.[28, 29, 30] These studies indicate that key signal transducers involved in the cAMP signaling pathway are promising targets for T2D intervention.